Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated : 06/20/2022

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications

Alpha-mannosidosis in Tunisian consanguineous families: Potential involvement of variants in GHR and SLC19A3 genes in the variable expressivity of cognitive impairment.

Journal: PloS one
Published: October 06, 2021
View publication
Summary: Alpha-mannosidosis in Tunisian consanguineous families: Potential involvement of variants in GHR and SLC19A3 genes in the variable expressivity of cognitive impairment.

Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial.

Condition: Alpha-Mannosidosis
Journal: Journal of inherited metabolic disease
Treatment Used: Velmanase Alfa
Number of Patients: 25
Published: May 31, 2018
View publication
Summary: Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial.

Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis.

Condition: Patients with Alpha-Mannosidosis (AM)
Journal: Journal of inherited metabolic disease
Treatment Used: Recombinant Human Alpha-Mannosidase (Velmanase Alfa)
Number of Patients: 33
Published: May 05, 2018
View publication
Summary: Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis.
Showing 1-3 of 3

Last Updated : 06/20/2022